￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
FDA approves Nerandomilast-Jascayd to treat idiopathic pulmonary fibrosis

2026-02-01 22:25:32

Check Details
NICE recommends first-line lorlatinib/lorlatinib for patients with newly diagnosed ALK+ NSCLC

2026-02-01 22:25:32

Check Details
Cabozantinib usage and dosage

2026-02-01 22:25:32

Check Details
Detailed instructions for Bosutinib

2026-02-01 22:25:32

Check Details
What will the approximate medical insurance price of nintedanib be in 2025?

2026-02-01 22:25:32

Check Details
Analysis of the real efficacy and side effects of Adagrasib in KRAS mutated non-small cell lung cancer, and price purchase channels at home and abroad

2026-02-01 22:25:32

Check Details
Safety data sharing of Platinib (Pujihua) in patients of different ages

2026-02-01 22:25:32

Check Details
Analysis of the effect and applicable population of capmatinib (Tourad) postoperative adjuvant therapy

2026-02-01 22:25:32

Check Details
Sotorasib (AMG 510) vs immunotherapy: Which is better for KRAS mutations?

2026-02-01 22:25:32

Check Details
Clinical data analysis of how long adagrasib (Krazati) can prolong survival after taking it

2026-02-01 22:25:32

Check Details
Content analysis and key medication information of Pimitespib instructions

2026-02-01 22:25:32

Check Details
Comparison of the differences and advantages between domestic and imported versions of Afatinib

2026-02-01 22:25:32

Check Details
Category
相关知识